Ensign Peak Advisors
BOLD

Ensign Peak Advisors’s Boundless Bio BOLD Stock Holding History

Ensign Peak Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Hold
187,500
– – ﹤0.01% 1297
2025
Q4 		$225K Hold
187,500
– – ﹤0.01% 1261
2025
Q3 		$231K Hold
187,500
– – ﹤0.01% 1628
2025
Q2 		$189K Hold
187,500
– – ﹤0.01% 1682
2025
Q1 		$283K Hold
187,500
– – ﹤0.01% 1646
2024
Q4 		$544K Hold
187,500
– – ﹤0.01% 1581
2024
Q3 		$651K Sell
187,500
-177,186
-49% -$642K ﹤0.01% 1536
2024
Q2 		$1.41M Sell
364,686
-10,314
-3% -$98.6K ﹤0.01% 1065
2024
Q1 		$5.34M Buy
+375,000
New +$5.34M 0.01% 622

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Ensign Peak Advisors's BOLD Position: Q1 2026 in Review

Ensign Peak Advisors held its Boundless Bio (BOLD) position steady in Q1 2026 at 187,500 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Ensign Peak Advisors first reported a position in BOLD in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.34M in Q1 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Ensign Peak Advisors held 187,500 shares of Boundless Bio worth $206K as of Q1 2026.
  • Ensign Peak Advisors left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q1 2026, its #1297 holding.
  • Ensign Peak Advisors first reported a position in Boundless Bio in Q1 2024 and has held it in 9 quarters since.
  • Ensign Peak Advisors's Boundless Bio position peaked at $5.34M in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.